LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/4WEB Sues NuVasive for Alleged Patent Infringement
Legal & Regulatory and Reimbursement

4WEB Sues NuVasive for Alleged Patent Infringement

April 26, 2023 2 min read Premium comments

Advertisement

4WEB Sues NuVasive for Alleged Patent Infringement
Courtesy of 4WEB Medical and NuVasive, Inc
#nuvasive#4webmedical#4web

Yesterday, April 25, 2023, Texas-based spinal implant company, 4WEB Medical filed a lawsuit against soon to be acquired NuVasive, Inc. (NuVasive and Globus Medical, Inc. are merging), accusing the Carlsbad, California company of infringing several of its key patents relating to 3D printed spinal implant designs.

4WEB, which has built its business on the unique, 3D printed spinal implant design which features web like geometries that create a high-strength yet lightweight truss implant, is claiming that NuVasive’s Modulus family of spine implants violate 4WEB’s patents.

4WEB’s Claims

4WEB’s patents could not have been possible without the innovation of 3D printing. Today, every manufacturer of orthopedic and spine implants is employing 3D printing technology in order to create innovative, lighter, stronger and more biologically active and ultimately more routinely successful implants.

4WEB’s patents teach a particular design for 3D spinal implants which relies on a truss strut architecture (see image of 4WEB’s Lateral Spine Truss implant) which has been shown in several studies by such well-known academic centers as the University of Pennsylvania to produce strains in the adjacent bone tissue after implant which, according to these studies, promote bone growth and spine fusion. In other words, as 4WEB has claimed in its marketing, the structure of the implant itself is actively participating in the healing process.

In its lawsuit, 4WEB is claiming that NuVasive’s Modulus is violating the claims in 11 different 4WEB owned patents.

NuVasive and 4WEB’s Failed Acquisition Talks in 2015

In early 2015, the two companies were talking merger or acquisition. 4WEB’s executives, Jessee Hunt and Jim Bruty, met with NuVasive’s head of corporate development Augustus (“Gusty”) Denis and on May 5, 2015, both companies signed non-disclosure and non-use agreements. According to 4WEB’s court filing, the talks between the two companies ended in August 2015 when the two companies could not agree on a valuation.

Advertisement

According to 4WEB’s lawsuit, after the acquisition talks ended in 2015, NuVasive developed and then brought to market the Modulus series of spinal implants which were also 3D printed and also relied on a truss architecture.

NuVasive, as it is in the final days before being acquired in a stock transaction with Globus Medical, will be responding.

No dollar amount was set in the filing, but 4WEB did accuse NuVasive of willful patent infringement and is asking for treble damages if a jury agrees with that claim.

More details to follow. Stay tuned for more on this strategically important case.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy